Dr Joaquin Mateo speaks to ecancer about his talk from the ESMO 2022 special session.
He discusses complex technologies for advanced diagnosis and precision medicine in oncology.
Dr Mateo initially explains the promise of precision medicine and how it can open avenues to improved cancer treatment. He then talks about the ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe.
Dr Mateo further discusses drug access, decision support tools, and ESMO recommendations on multigene NGS.
He concludes by talking about incorporating ESCAT and ESMO guidelines in the recommendations for biomarker testing and drug matching.